Ilze Mutule

Discovery of a Novel Superpotent and Selective Melanocortin-4 Receptor Antagonist (HS024): Evaluation in Vitro and in Vivo**This work was supported by grants from the Swedish Medical Research Council (04X-05957), the Swedish Society for Medical Research, and the Estonian Science Foundation (Grant 3267); the Ants ja Maria Silvere ning Sigfried Panti Malestusstipendium Foundation (to A.K.); and the Swedish Institute (to I.M.).

Ants Kask, Felikss Mutulis, Ruta Muceniece et al. · Endocrinology · 1998 · 155 citations

The MC4 receptor mediates α-MSH induced release of nucleus accumbens dopamine

Jonas Lindblom, Baiba Opmane, Felikss Mutulis et al. · Neuroreport · 2001 · 104 citations

Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist

Gudrún V. Skúladóttir, Logi Jónsson, J. O. SKARPHEDINSSON et al. · British Journal of Pharmacology · 1999 · 78 citations · Full text

Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides

Pornwaratt Niyomrattanakit, Sviatlana Yahorava, Ilze Mutule et al. · Biochemical Journal · 2006 · 56 citations · Full text

Dengue Virus, Virus Maturation, Molecular Biology +17

Plasmepsin Inhibitory Activity and Structure-Guided Optimization of a Potent Hydroxyethylamine-Based Antimalarial Hit

Kristaps Jaudzems, Kaspars Tārs, Gundars Maurops et al. · ACS Medicinal Chemistry Letters · 2014 · 55 citations · Full text

Inhibitory Activity, Medicinal Chemistry, Plasmepsin Inhibitory Activity +15